Adage Capital Partners
TENX icon

Adage Capital Partners’s Tenax Therapeutics TENX Stock Holding History

Adage Capital Partners’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.64M Buy
540,126
+456,793
+548% +$6.18M 0.01% 720
2025
Q4 		$1.02M Hold
83,333
– – ﹤0.01% 854
2025
Q3 		$634K Hold
83,333
– – ﹤0.01% 841
2025
Q2 		$480K Hold
83,333
– – ﹤0.01% 810
2025
Q1 		$546K Hold
83,333
– – ﹤0.01% 810
2024
Q4 		$516K Hold
83,333
– – ﹤0.01% 839
2024
Q3 		$288K Buy
+83,333
New +$302K ﹤0.01% 824

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners's TENX Position: Q1 2026 in Review

Adage Capital Partners increased its Tenax Therapeutics (TENX) stake by 548% in Q1 2026, buying an estimated $6.18M and bringing the position to 540,126 shares worth $8.64M. The position accounts for 0.01% of the portfolio, ranked #720.

Adage Capital Partners first reported a position in TENX in Q3 2024 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Adage Capital Partners held 540,126 shares of Tenax Therapeutics worth $8.64M as of Q1 2026.
  • Adage Capital Partners bought 456,793 Tenax Therapeutics shares in Q1 2026, an estimated $6.18M.
  • Tenax Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #720 holding.
  • Adage Capital Partners first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.